Inventor · disambiguated record
Lawrence J. Marnett
Also filed as: MARNETT LAWRENCE J
27 granted patents·6 pending applications·357 citations·filing 1985–2023
97Inventor score
Files withUNIV VANDERBILT24MARNETT LAWRENCE J3UNIV WAYNE STATE3UNIV PENNSYLVANIA2BIOMIDE INVESTMENT LP1
Top patents by PatentIndex Score
33 records- 0193US7491744B2Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicityUNIV VANDERBILT·Filed 2005·Granted Feb 17, 2009·25 cites·7 claims
- 0291US5234933ACyclic hydroxamic acidsUNIV WAYNE STATE·Filed 1991·Granted Aug 10, 1993·50 cites·9 claims
- 0389US9895351B2Indomethacin analogs for the treatment of castrate-resistant prostate cancerUNIV VANDERBILT·Filed 2016·Granted Feb 20, 2018·4 cites·14 claims
- 0487US7736624B2Methods and compositions for diagnostic and therapeutic targeting of COX-2UNIV VANDERBILT·Filed 2007·Granted Jun 15, 2010·13 cites·21 claims
- 0587US6399647B2Amide derivatives for antiangiogenic and/or antitumorigenic useUNIV VANDERBILT·Filed 2001·Granted Jun 4, 2002·24 cites·14 claims
- 0687US5475021ACompounds and compositions for inhibition of cyclooxygenase activityUNIV VANDERBILT·Filed 1993·Granted Dec 12, 1995·33 cites·44 claims
- 0786US10398678B2Indomethacin analogs for the treatment of castrate-resistant prostate cancerUNIV VANDERBILT·Filed 2018·Granted Sep 3, 2019·2 cites·14 claims
- 0886US9346803B2Indomethacin analogs for the treatment of castrate-resistant prostate cancerUNIV VANDERBILT·Filed 2012·Granted May 24, 2016·4 cites·10 claims
- 0986US8168656B2Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicityMARNETT LAWRENCE J·Filed 2009·Granted May 1, 2012·9 cites·10 claims
- 1085US8143302B2Methods and compositions for diagnostic and therapeutic targeting of COX-2MARNETT LAWRENCE J·Filed 2010·Granted Mar 27, 2012·12 cites·43 claims
- 1180US8865130B2Methods and compositions for diagnostic and therapeutic targeting of COX-2MARNETT LAWRENCE J·Filed 2012·Granted Oct 21, 2014·6 cites·24 claims
- 1277US11459295B22-beta-naphthyl-acetic acid analogs as AKR1C3 inhibitors and methods of using sameUNIV PENNSYLVANIA·Filed 2016·Granted Oct 4, 2022·1 cites·17 claims
- 1377US6306890B1Esters derived from indolealkanols and novel amides derived from indolealkylamides that are selective COX-2 inhibitorsUNIV VANDERBILT·Filed 1999·Granted Oct 23, 2001·42 cites·10 claims
- 1473US11738004B2Indomethacin analogs for the treatment of castrate-resistant prostate cancerUNIV VANDERBILT·Filed 2021·Granted Aug 29, 2023·0 cites·14 claims
- 1573US7189504B2Compositions and methods for detecting and quantifying COX-2 activity and 2-arachidonylglycerol metabolitesUNIV VANDERBILT·Filed 2001·Granted Mar 13, 2007·9 cites·37 claims
- 1672US6207700B1Amide derivatives for antiangiogenic and/or antitumorigenic useUNIV VANDERBILT·Filed 1999·Granted Mar 27, 2001·27 cites·11 claims
- 1772US5973191ASelective inhibitors of prostaglandin endoperoxide synthase-2UNIV VANDERBILT·Filed 1996·Granted Oct 26, 1999·27 cites·22 claims
- 1870US7628975B2Compositions and methods for detecting and quantifying COX-2 activity and 2-arachidonylgycerol metabolitesUNIV VANDERBILT·Filed 2005·Granted Dec 8, 2009·2 cites·21 claims
- 1969US2023039244A12-beta-naphthyl-acetic acid analogs as akr1c3 inhibitors and methods of using sameUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 2067US2019350903A1Indomethacin analogs for the treatment of castrate-resistant prostate cancerUNIV VANDERBILT·Filed 2019·Application pending·0 cites
- 2165US2009252678A1Cox-2-targeted imaging agentsUNIV VANDERBILT·Filed 2009·Application pending·0 cites
- 2262US4780281AMethod for assay of peroxidase enzyme or reducing substrate activityUNIV WAYNE STATE·Filed 1985·Granted Oct 25, 1988·25 cites·18 claims
- 2361US5238832AAryl aliphatic acidsUNIV WAYNE STATE·Filed 1992·Granted Aug 24, 1993·9 cites·70 claims
- 2457US6762182B1Converting cox inhibition compounds that are not COX-2 selective inhibitors to derivatives that are COX-2 selective inhibitorsUNIV VANDERBILT·Filed 1999·Granted Jul 13, 2004·18 cites·16 claims
- 2557US6284918B1Selective inhibitors of prostaglandin endoperoxide synthase-2UNIV VANDERBILT·Filed 1999·Granted Sep 4, 2001·12 cites·4 claims
- 2656US10792377B2Compounds and method for imaging cancerUNIV VANDERBILT·Filed 2018·Granted Oct 6, 2020·0 cites·20 claims
- 2754US2025242062A1Anti-cox-2 nanobodies for endoscopic visualization of colorectal adenomasUNIV VANDERBILT·Filed 2023·Application pending·0 cites
- 2851US2005002859A1COX-2-targeted imaging agentsUNIV VANDERBILT·Filed 2004·Application pending·0 cites
- 2950US5292884ACyclic hydroxamic acidsBIOMIDE INVESTMENT LP·Filed 1992·Granted Mar 8, 1994·3 cites·4 claims
- 3045US10105455B2Fluorocoxib A loading into ROS-responsive nanoparticlesUNIV VANDERBILT·Filed 2016·Granted Oct 23, 2018·0 cites·13 claims
- 3143US2015183737A1Compositions and methods for substrate-selective inhibition of endocannabinoid oxygenationUNIV VANDERBILT·Filed 2013·Application pending·0 cites
- 3242US7314709B2Compositions and methods for detecting and quantifying COX-2 activity by lipoamino acid metabolismUNIV VANDERBILT·Filed 2002·Granted Jan 1, 2008·0 cites·10 claims
- 3332US10695446B2Composition and method for detecting hypoxiaUNIV VANDERBILT·Filed 2016·Granted Jun 30, 2020·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Lawrence J. Marnett files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →